Table of Contents Table of Contents
Previous Page  408 / 1096 Next Page
Information
Show Menu
Previous Page 408 / 1096 Next Page
Page Background

S393

ESTRO 36

_______________________________________________________________________________________________

Purpose or Objective

The use of stereotactic body radiation therapy (SBRT) is

increasing rapidly in patients with bone metastases. This

technique involves high precision dose delivery, for which

accurate gross tumor volume (GTV) contouring is crucial.

This study compares inter-observer agreement in bone

metastases delineated on CT, MR and CT with co-

registered MR imaging.

Material and Methods

Twenty consecutive patients with bone metastases

treated with SBRT were selected. All patients received CT

and MR imaging in treatment position prior to

radiotherapy. CT images were obtained with a Philips

large bore CT scanner (1 mm slice thickness). A Philips 1.5

Tesla MRI scanner was used to acquire T1- and T2-

weighted images in transversal direction. Coronal and/or

sagittal images were acquired, including 3D T1FFE mDIXON

scan (slice thickness 1.1mm) and diffusion weighted

imaging (slice thickness 4 mm). Five observers from three

institutions independently delineated GTV after a training

set of two patients and a consensus meeting. First, GTV

was delineated on CT images only. A second delineation

was based on CT images with co-registered MR images. At

least four weeks after the delineation on CT-MR combined,

the GTV was contoured on MR imaging only. Average

volumes of the contours per patient and imaging modality

were calculated. The generalized conformity index (CI)

was used to quantify inter-observer agreement.

Significant differences between the average volumes and

CI were analyzed by Wilcoxon signed rank test. Observer

count maps were generated for visual comparison of

agreement for each case and imaging modality.

Results

Mean GTV volume delineated on MR (43.4 ± 49.7 cm

3

) was

larger compared to CT-MR (40.2 ± 49.4 cm

3

) and CT (34.8

± 34.8 cm

3

). Compared to CT, the mean volume of GTV

was 11% larger on CT-MR and 35% on MR (Figure 1B). A

large variation in CI was found in all imaging

modalities: CT (range: 0.15-0.75), CT-MR (range: 0.17-

0.71) and MR (0.14-0.80). Mean CI were significantly

higher on CT-MR compared to CT (Table 1). An example of

a count map is shown (case 18, Figure 1B). For this case,

mean volume of the GTV was almost doubled on MR

compared to CT, which might be explained by better

visibility of the extra-osseous disease on MR imaging.

Conclusion

This multicenter contouring study demonstrated large

inter-observer variation in GTV delineation for all

investigated imaging modalities. Delineation of GTV on MR

imaging resulted in larger volumes and marginal better

inter-observer agreement compared to CT only

delineations. These results suggest that future research

should focus on guidelines to improve agreement on GTV

delineation in these spine and non-spine bony metastases.

PO-0747 Setting defaults in palliative radiation: a

value-driven approach to improving care

L. Puckett

1

, L. Lee

1

, I. Zhang

1

, P. Zuvic

1

, P. Gilbo

1

, L.

Potters

1

, B. Bloom

1

1

Northwell Health / Hofstra Northwell School of

Medicine, Radiation Medicine, Lake Success, USA

Purpose or Objective

Single fraction (fx) and hypofractionated (1 or 5 fx)

radiation treatment (RT) provide superior value and

reduced treatment length in the palliation of bone

metastases. Despite data and recent guidelines

recommending reduced treatment duration, there has

been a slow adoption of this practice in the USA and

worldwide. Previous examination of our academic and

community multi-center practice from 2004 - 2016

revealed that single fx RT utilization has remained at 16%

and hypofractionationed courses have remained at 72%

since 2012. We hypothesized that enacting evidence-

based, treatment-guiding defaults would further increase

hypofractionation utilization.

Material and Methods

Institutionally, palliative bone metastasis treatments are

monitored by our Quality Assurance (QA) committee. On

2/29/2016, two distinct consensus-driven and evidence-

based clinical directives were created within our

electronic health system for use with either simple or

complicated bone metastasis, irrespective of primary

histology. The simple and complex treatment directives

had default prescriptions of 8 Gy/1fx or 20 Gy/5fx,